Quick Answer
CytoDyn Inc. reported Total Revenue of $0.00 for fiscal year 2023.
CytoDyn Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2023 | $0.00 | -100.0% |
| 2022 | $266.0K | — |
| 2021 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| November 30, 2021 | $225.0K | — | +448.8% |
| August 31, 2021 | $41.0K | — | — |
| August 31, 2020 | $0.00 | — | — |
- CytoDyn Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from CytoDyn Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on September 14, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: